Playback speed
10 seconds
ELCC 2023 on Long-Term Efficacy, Safety & Predictors of Response to Amivantamab Among Patients With Post-Platinum EGFR ex20ins-Mutated Advanced NSCLC
By
ecancer
FEATURING
Nicolas Girard
By
ecancer
FEATURING
Nicolas Girard
440 views
May 9, 2023
Comments 0
Login to view comments.
Click here to Login